Handelsbanken Fonder’s Minerva Neurosciences NERV Stock Holding History

Handelsbanken Fonder’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-31,875	Closed	-$1.98M	–	187
2019 Q3	$1.98M	Hold	31,875	–	–	0.04%	166
2019 Q2	$1.44M	Hold	31,875	–	–	0.03%	175
2019 Q1	$2M	Buy	31,875 +6,250	+24%	+$376K	0.04%	169
2018 Q4	$1.38M	Hold	25,625	–	–	0.03%	158
2018 Q3	$2.57M	Buy	25,625 +10,000	+64%	+$751K	0.05%	162
2018 Q2	$1.03M	Buy	15,625 +3,750	+32%	+$228K	0.02%	180
2018 Q1	$594K	Hold	11,875	–	–	0.01%	183
2017 Q4	$575K	Hold	11,875	–	–	0.01%	174
2017 Q3	$722K	Buy	+11,875	New	+$681K	0.02%	169
2017 Q2	–	Sell	-11,875	Closed	-$770K	–	177
2017 Q1	$770K	Buy	11,875 +3,125	+36%	+$243K	0.02%	163
2016 Q4	$822K	Hold	8,750	–	–	0.03%	147
2016 Q3	$988K	Buy	8,750 +2,500	+40%	+$243K	0.03%	148
2016 Q2	$510K	Buy	+6,250	New	+$397K	0.02%	155

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IVAI

Index Venture Associates IV St. Helier, Channel Islands, Jersey $6.24M AUM

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Handelsbanken Fonder's NERV Position: Q4 2019 in Review

Handelsbanken Fonder sold out of Minerva Neurosciences (NERV) in Q4 2019, closing a stake of 31,875 shares — an estimated $1.98M sold.

Handelsbanken Fonder first reported a position in NERV in Q2 2016 and held it in 13 quarters. The position peaked at $2.57M in Q3 2018. 92 funds tracked by Wall St. Rank hold NERV as of Q4 2019.

Handelsbanken Fonder reported no remaining Minerva Neurosciences position as of Q4 2019 after selling out during the quarter.
Handelsbanken Fonder sold 31,875 Minerva Neurosciences shares in Q4 2019, an estimated $1.98M.
Handelsbanken Fonder first reported a position in Minerva Neurosciences in Q2 2016 and held it in 13 quarters.
Handelsbanken Fonder's Minerva Neurosciences position peaked at $2.57M in Q3 2018.
92 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2019.

Based on Handelsbanken Fonder's 13F filing for Q4 2019, filed 14 Feb 2020.